Sionna Therapeutics (SION) Current Leases (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Current Leases data on file, last reported at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 18.14% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 18.14% YoY), and the FY2025 full-year result was $1.3 million, up 18.38% from the prior year.
• Current Leases advanced to $1.3 million in Q1 2026, from $1.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.3 million in Q1 2026 to a low of $1.1 million in Q4 2024.
• A 3-year average of $1.2 million and a median of $1.2 million in 2025 frame the typical range for Current Leases.
• Across the five-year window, Current Leases advanced 18.38% in 2025 and grew 18.14% in 2026, its largest moves.
• Tracing SION's Current Leases over 3 years: stood at $1.1 million in 2024, then rose by 18.38% to $1.3 million in 2025, then rose by 4.18% to $1.3 million in 2026.
• Business Quant data shows SION's Current Leases at $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.2 million in Q3 2025.